期刊文献+

复方甘草酸苷联合左西替利嗪及酮替芬治疗慢性荨麻疹的临床效果 被引量:1

Treatment of compound glycyrrhizin combined with levocetirizine and ketotifen on chronic urticaria
下载PDF
导出
摘要 目的:探讨复方甘草酸苷联合左西替利嗪及酮替芬治疗慢性荨麻疹的疗效和可行性。方法:选取2015年6月至2016年6月我院收治的80例慢性荨麻疹患者,随机分为对照组(38例)和治疗组(42例)。对照组以左西替利嗪和酮替芬治疗。在对照组治疗基础上,治疗组加服复方甘草酸苷胶囊75mg tid。均连用4周后,比较两组的有效率。结果:治疗组和对照组有效率分别为85.71%和57.89%。两组比较差异有统计学意义(P<0.01)。结论:复方甘草酸苷联合左西替利嗪及酮替芬治疗慢性荨麻疹的疗效满意,值得临床选择应用。 Objective:To study the effect of compound glycyrrhizin combined with levocetirizine and ketotifen on chronic urticaria.Methods:Eighty patients with chronic urticaria from June 2015 to June 2016 were divided randomly into control group(38cases)and treatment group(42cases).Patients in control group were only treated with orally levocetirizine and ketotifen,and patients of treatment group were treated with orally compound glycyrrhizin 75 mg tid,combined with levocetirizine and ketotifen.The treatment period was 4weeks,then effective rate were compared.Results:The effective rates of treatment and control group were 85.71% and57.89% respectively,which had statistical difference(P〈0.01).Conclusion:The treatment result of chronic urticaria with compound glycyrrhizin combined with levocetirizine and ketotifen is effective,and worth to use in clinic.
作者 史修波 兰小琼 佘冬华 Shi Xiu-Bo Lan Xiao-Qiong She Dong-hua(Department of Dermatology, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Sichuan Chengdu 610041)
出处 《四川生理科学杂志》 2016年第3期165-167,共3页 Sichuan Journal of Physiological Sciences
关键词 复方甘草酸苷 左西替利嗪 酮替芬 荨麻疹 Compound glycyrrhizin Levocetirizine Ketotifen Urticaria
  • 相关文献

参考文献7

二级参考文献64

  • 1雷小兵,高冬,张江安,吕敏贤,冉立伟,刘安,谭升顺.咪唑斯汀联合甘草酸二铵治疗慢性荨麻疹疗效观察[J].临床皮肤科杂志,2004,33(11):705-705. 被引量:9
  • 2刘丽丽,张焕梅,刘志军.衡阳地区575例慢性荨麻疹患者过敏原检测分析[J].实用全科医学,2007,5(5):381-382. 被引量:5
  • 3[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 4[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 5[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 6[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 7[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 8[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 9[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 10[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.

共引文献231

同被引文献2

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部